Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
uBio Biotechnology Systems is an Indian in vitro diagnostics and medical device company focused on human, veterinary, and food diagnostic products. The company develops, manufactures, and commercializes rapid tests, ELISA kits, molecular diagnostics, biosensor-based assays, and related sample collection and nucleic-acid handling products. Its portfolio includes infectious disease tests, point-of-care fluorescence assays, veterinary rapid diagnostics, and COVID-19 molecular tools, and it also offers assay development, technology transfer, OEM supply, and contract manufacturing services. uBio operates an ISO 13485-certified and GMP-certified manufacturing facility in Kochi, Kerala, and highlights capabilities spanning recombinant proteins, monoclonal antibodies, microarray chips, and biosensor manufacturing. The business appears to be primarily a commercial diagnostics platform and manufacturing company rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on uBio Biotechnology Systems.